Our findings emphasize the importance of Nectin-4 as a novel diagnostic tool and screening marker for assessing endometrial cancer and improving the accuracy of approaches used to predict high-risk endometrial cancer. This evidence concerns the gene NECTIN4 and endometrial cancer.